ABPI response to new funding for UK medicines manufacturing

The Government has today announced £60million to help expand life sciences manufacturing in the UK.  

Investing in hi-tech, UK manufacturing has never been more important. ABPI Chief Executive Richard Torbett

The ABPI welcomed the announcement

Responding to the manufacturing fund, ABPI Chief Executive Richard Torbett said:

“This announcement will strengthen our sector and help the government realise its Vision for Life Sciences. Such funding was called for by our members, who are keen to invest in the latest manufacturing technologies in the UK.

Investing in hi-tech, UK manufacturing has never been more important. We look forward to hearing more about how the Fund will work and continuing to work with Government to make a real difference to UK growth as well as resilience to future pandemics and climate change.” 

  • Manufacturing

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.